Literature DB >> 14612923

In situ detection of telomeres by fluorescence in situ hybridization and telomerase activity in glioblastoma multiforme: correlation with p53 status, EGFR, c-myc, MIB1, and Topoisomerase IIalpha protein expression.

Clelia Miracco1, M Margherita De Santi, Pietro Luzi, Anna Vittoria Lalinga, Lorella Laurini, Maria Caterina De Nisi, Giuseppina Angeloni, Marco Brogi, Concetta Cardone, Antonietta Carducci, Felice Arcuri, Piero Tosi, Giovanni Rubino, Luigi Pirtoli.   

Abstract

Aberrations of genes/proteins regulating cell cycle and growth, increased proliferation and telomerase activity (TA) are documentable in glioblastoma multiforme. TA is more frequently detectable in secondary glioblastoma, which is also characterized by p53 mutation/overexpression. Discordant telomere (Te) length values have been reported in glioblastomas with and without TA. In 31 glioblastomas, in which pre-existing astrocytoma was not documented, we compared cases with and without TA for the expression of p53, EGFR, c-Myc, MIB-1 and Topoisomerase IIalpha; p53 mutations were also investigated by SSCP-PCR. Correlations were made with Te parameters [TePs: number (TeNo), length and area] as evaluated by image analysis in interphase nuclei of fluorescence in situ hybridization (FISH)-processed sections. We found no differences in the expression of the proteins evaluated and in TePs, except Te/nuclear area %, which was significantly lower in TA+ cases (p=0.02). TePs were, instead, inversely correlated with TA (p=0.0001). TA was positively correlated with MIB1 staining index in the TA+ cases (p=0.033), which also showed a positive correlation between TeNo and EGFR expression (p=0.042), and a trend towards a negative correlation between TeNo and p53 expression (p=0.05). Tumors overexpressing EGFR had a significantly shorter lifetime (p=0.0001). TeNo seems to be inversely correlated to tumor proliferation and lifetime in glioblastoma multiforme.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14612923

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  5 in total

1.  EGFR expression stratifies oligodendroglioma behavior.

Authors:  Craig Horbinski; Jonathan Hobbs; Kathleen Cieply; Sanja Dacic; Ronald L Hamilton
Journal:  Am J Pathol       Date:  2011-08-11       Impact factor: 4.307

Review 2.  Glioma: what is the role of c-Myc, hsp90 and telomerase?

Authors:  A Shervington; N Cruickshanks; H Wright; R Atkinson-Dell; R Lea; G Roberts; L Shervington
Journal:  Mol Cell Biochem       Date:  2006-02       Impact factor: 3.396

3.  p300- and Myc-mediated regulation of glioblastoma multiforme cell differentiation.

Authors:  Sreejith P Panicker; Baisakhi Raychaudhuri; Pankaj Sharma; Russell Tipps; Tapati Mazumdar; Asoke K Mal; Juan M Palomo; Michael A Vogelbaum; Saikh Jaharul Haque
Journal:  Oncotarget       Date:  2010-08

4.  Loss of MYC and E-box3 binding contributes to defective MYC-mediated transcriptional suppression of human MC-let-7a-1~let-7d in glioblastoma.

Authors:  Zifeng Wang; Sheng Lin; Ji Zhang; Zhenhua Xu; Yu Xiang; Hong Yao; Lei Ge; Dan Xie; Hsiang-Fu Kung; Gang Lu; Wai Sang Poon; Quentin Liu; Marie Chia-Mi Lin
Journal:  Oncotarget       Date:  2016-08-30

5.  Prognostic molecular markers with no impact on decision-making: the paradox of gliomas based on a prospective study.

Authors:  M Wager; P Menei; J Guilhot; P Levillain; S Michalak; B Bataille; J-L Blanc; F Lapierre; P Rigoard; S Milin; F Duthe; D Bonneau; C-J Larsen; L Karayan-Tapon
Journal:  Br J Cancer       Date:  2008-05-27       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.